Letter: Mendelian randomization --new perspective in inflammatory bowel disease and pancreatic cancer? Authors' reply

被引：1
|
作者：
Massironi, Sara [1 ]
Vigano, Chiara [1 ]
Danese, Silvio [2 ,3 ]
机构：
[1] Fdn IRCCS San Gerardo Dei Tintori, Gastroenterol Unit, Monza, MB, Italy
[2] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, Milan, Italy
[3] Univ Vita & Salute San Raffaele, Milan, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 01期
关键词：
D O I：
10.1111/apt.17552
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Massironi et al papers. To view these articles, visit and
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [41] Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply
    Malham, Mikkel
    Jakobsen, Christian
    Paerregaard, Anders
    Hald, Mette
    Virta, Lauri
    Kolho, Kaija-Leena
    Wewer, Vibeke
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (11) : 1214 - 1215
  • [42] Letter: phenotype and natural history of elderly onset inflammatory bowel disease-Authors' reply
    Manosa, M.
    Domenech, E.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1421 - 1422
  • [43] Letter: association between COVID-19 and inflammatory bowel disease-Authors' reply
    Hadi, Yousaf
    Kochhar, Gursimran S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (09) : 1228 - 1229
  • [44] Letter: inflammatory bowel disease services during the Covid-19 pandemic - authors' reply
    Deputy, Mohammed
    Hart, Ailsa
    Faiz, Omar
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1064 - 1064
  • [45] Letter: Persisting with persistence-A caution as an outcome measure in inflammatory bowel disease: Authors' reply
    Yiu, Tsz Hong
    Ko, Yanna
    Pudipeddi, Aviv
    Natale, Patrizia
    Leong, Rupert W.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (03) : 427 - 428
  • [46] Assessing inflammatory protein factors in inflammatory bowel Disease using multivariable mendelian randomization
    Su, Qiang
    Lu, Yun
    He, Song
    Liang, Jiang
    Huang, Song
    He, Yuanli
    An, Zhenxiang
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [47] Letter: validated fatigue questionnaires in inflammatory bowel diseases - authors' reply
    Czuber-Dochan, W.
    Norton, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (03) : 342 - 342
  • [48] Letter: combination of biologics in inflammatory bowel diseases. Authors' reply
    Yang, Edward
    Panaccione, Nicola
    Whitmire, Natalie
    Dulai, Parambir S.
    Vande Casteele, Niels
    Singh, Siddharth
    Boland, Brigid S.
    Collins, Angelina
    Sandborn, William J.
    Panaccione, Remo
    Battat, Robert
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (03) : 568 - 569
  • [49] Treatment of anaemia in inflammatory bowel disease: authors' reply
    de Silva, A
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1274 - 1275
  • [50] Association between inflammatory bowel disease and Parkinson's disease: A Mendelian randomization study
    Freuer, D.
    Meisinger, C.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
12345